Market Tracker

12/19 6:05pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

7.25
Data as of Dec 19
 -0.095 / -1.29%
Today’s Change
3.10
Today|||52-Week Range
7.57
+36.02%
Year-to-Date
The Frantic Hunt for Performance
Dec 18 / TheStreet.com
Dip Buying in Full Force
Dec 18 / TheStreet.com
Give the Bulls Room to Run
Dec 18 / TheStreet.com
 

Today’s Trading

Previous close7.35
Today’s open7.34
Day’s range7.21 - 7.57
Volume6,108,494
Average volume (3 months)1,139,818
Market cap$504.3M
Dividend yield--
Data as of 3:59pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+115.79%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratio145.0
Price/Sales37.83
Price/Book5.58

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc-1.45-6.67%
XNPTXenoport Inc+0.29+3.67%
ZIOPZIOPHARM Oncology In...+0.53+12.41%
ITCIIntra-Cellular Thera...-0.58-3.35%
Data as of 4:14pm ET, 12/19/2014

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts